These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 33427016)
1. Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis. Freeman AM; Mokrysz C; Hindocha C; Lawn W; Morgan CJ; Freeman TP; Saunders R; Curran HV J Psychopharmacol; 2021 Jul; 35(7):804-813. PubMed ID: 33427016 [TBL] [Abstract][Full Text] [Related]
2. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users. Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187 [TBL] [Abstract][Full Text] [Related]
3. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure. Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939 [TBL] [Abstract][Full Text] [Related]
4. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment. Lawn W; Trinci K; Mokrysz C; Borissova A; Ofori S; Petrilli K; Bloomfield M; Haniff ZR; Hall D; Fernandez-Vinson N; Wang S; Englund A; Chesney E; Wall MB; Freeman TP; Curran HV Addiction; 2023 Jul; 118(7):1282-1294. PubMed ID: 36750134 [TBL] [Abstract][Full Text] [Related]
5. Sex differences in the acute effects of intravenous (IV) delta-9 tetrahydrocannabinol (THC). Bassir Nia A; Orejarena MJ; Flynn L; Luddy C; D'Souza DC; Skosnik PD; Pittman B; Ranganathan M Psychopharmacology (Berl); 2022 May; 239(5):1621-1628. PubMed ID: 35438304 [TBL] [Abstract][Full Text] [Related]
6. Cannabis use and the development of tolerance: a systematic review of human evidence. Colizzi M; Bhattacharyya S Neurosci Biobehav Rev; 2018 Oct; 93():1-25. PubMed ID: 30056176 [TBL] [Abstract][Full Text] [Related]
7. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study. Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109 [TBL] [Abstract][Full Text] [Related]
8. Sex differences in the acute effects of oral THC: a randomized, placebo-controlled, crossover human laboratory study. Mohammad Aghaei A; Urban Spillane L; Pittman B; Flynn LT; De Aquino JP; Bassir Nia A; Ranganathan M Psychopharmacology (Berl); 2024 Oct; 241(10):2145-2155. PubMed ID: 38832949 [TBL] [Abstract][Full Text] [Related]
9. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans. Ranganathan M; De Aquino JP; Cortes-Briones JA; Radhakrishnan R; Pittman B; Bhakta S; D'Souza DC Psychopharmacology (Berl); 2019 Nov; 236(11):3209-3219. PubMed ID: 31187152 [TBL] [Abstract][Full Text] [Related]
10. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. D'Souza DC; Ranganathan M; Braley G; Gueorguieva R; Zimolo Z; Cooper T; Perry E; Krystal J Neuropsychopharmacology; 2008 Sep; 33(10):2505-16. PubMed ID: 18185500 [TBL] [Abstract][Full Text] [Related]
11. Acute effects of Δ9-tetrahydrocannabinol (THC) on resting state connectivity networks and impact of COMT genotype: A multi-site pharmacological fMRI study. Pelgrim TAD; Ramaekers JG; Wall MB; Freeman TP; Bossong MG Drug Alcohol Depend; 2023 Oct; 251():110925. PubMed ID: 37598453 [TBL] [Abstract][Full Text] [Related]
12. Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function. Morgan CJA; Freeman TP; Hindocha C; Schafer G; Gardner C; Curran HV Transl Psychiatry; 2018 Sep; 8(1):181. PubMed ID: 30185793 [TBL] [Abstract][Full Text] [Related]
13. Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies. Ganesh S; Cortes-Briones J; Ranganathan M; Radhakrishnan R; Skosnik PD; D'Souza DC Int J Neuropsychopharmacol; 2020 Dec; 23(9):559-570. PubMed ID: 32385508 [TBL] [Abstract][Full Text] [Related]
14. Acute effects of oral delta-9-tetrahydrocannabinol (THC) on autonomic cardiac activity and their relation to subjective and anxiogenic effects. Pabon E; Rockwood F; Norman GJ; de Wit H Psychophysiology; 2022 Feb; 59(2):e13955. PubMed ID: 34665890 [TBL] [Abstract][Full Text] [Related]
15. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme. Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550 [TBL] [Abstract][Full Text] [Related]
16. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. Mathai DS; Holst M; Rodgman C; Haile CN; Keller J; Hussain MZ; Kosten TR; Newton TF; Verrico CD J Neuropsychiatry Clin Neurosci; 2018; 30(1):66-76. PubMed ID: 28641496 [TBL] [Abstract][Full Text] [Related]
17. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC. Lile JA; Kelly TH; Hays LR Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600 [TBL] [Abstract][Full Text] [Related]
18. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers. Lundahl LH; Greenwald MK Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933 [TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
20. Sex differences in the subjective effects of oral Δ Fogel JS; Kelly TH; Westgate PM; Lile JA Pharmacol Biochem Behav; 2017 Jan; 152():44-51. PubMed ID: 26780348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]